Literature DB >> 26945273

Factors Influencing Selection of Vaginal, Open Abdominal, or Robotic Surgery to Treat Apical Vaginal Vault Prolapse.

Mallika Anand1, Amy L Weaver, Kristin M Fruth, John B Gebhart.   

Abstract

OBJECTIVES: This study aimed to determine factors influencing the selection of Mayo-McCall culdoplasty (MMC), open abdominal sacrocolpopexy (ASC), or robotic sacrocolpopexy (RSC) for posthysterectomy vaginal vault prolapse.
METHODS: We retrospectively searched for the records of patients undergoing posthysterectomy apical vaginal prolapse surgery between January 1, 2000, and June 30, 2012, at our institution. Baseline characteristics and explicit selection factors were abstracted from the electronic medical records. Factors were compared between groups using χ tests for categorical variables, analysis of variance for continuous variables, and Kruskal-Wallis tests for ordinal variables.
RESULTS: Among the 512 patients identified who met inclusion criteria, the MMC group (n = 174) had more patients who were older, had American Society of Anesthesiologists class 3+ or greater, had anterior vaginal prolapse grade 3+, desired to avoid abdominal surgery, and did not desire a functional vagina. Patients in the ASC (n = 237) and RSC (n = 101) groups had more failed prolapse surgeries, suspected abdominopelvic pathologic processes, and chronic pain. Advanced prolapse was more frequently cited as an explicit selection factor for ASC than for either MMC or RSC.
CONCLUSIONS: The most common factors that influenced the type of apical vaginal vault prolapse surgery overlapped with characteristics that differed at baseline. In general, MMC was chosen for advanced anterior vaginal prolapse and baseline characteristics that increased surgical risks, ASC for advanced apical prolapse, and ASC or RSC for recurrent prolapse, suspected abdominal pathology, and patients with chronic pain or lifestyles including heavy lifting. Thus, efforts should be made to attempt to control for selection bias when comparing these procedures.

Entities:  

Mesh:

Year:  2016        PMID: 26945273      PMCID: PMC4919143          DOI: 10.1097/SPV.0000000000000264

Source DB:  PubMed          Journal:  Female Pelvic Med Reconstr Surg        ISSN: 2151-8378            Impact factor:   2.091


  10 in total

1.  Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support.

Authors:  Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde
Journal:  J Biomed Inform       Date:  2008-09-30       Impact factor: 6.317

2.  Apical vaginal prolapse surgery: practice patterns and factors guiding route of repair.

Authors:  T Ignacio Montoya; Kathryn B Grande; David D Rahn
Journal:  Female Pelvic Med Reconstr Surg       Date:  2012 Nov-Dec       Impact factor: 2.091

3.  The UK national prolapse survey: 5 years on.

Authors:  Swati Jha; Paul Moran
Journal:  Int Urogynecol J       Date:  2011-02-22       Impact factor: 2.894

4.  Genesis of the vaginal profile: a correlated classification of vaginal relaxation.

Authors:  W F Baden; T A Walker
Journal:  Clin Obstet Gynecol       Date:  1972-12       Impact factor: 2.190

5.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

Authors:  M E Charlson; P Pompei; K L Ales; C R MacKenzie
Journal:  J Chronic Dis       Date:  1987

6.  Survey of current management of prolapse in Australia and New Zealand.

Authors:  Ruben Vanspauwen; Elvis Seman; Peter Dwyer
Journal:  Aust N Z J Obstet Gynaecol       Date:  2010-06       Impact factor: 2.100

7.  True incidence of vaginal vault prolapse. Thirteen years of experience.

Authors:  M Marchionni; G L Bracco; V Checcucci; A Carabaneanu; E M Coccia; F Mecacci; G Scarselli
Journal:  J Reprod Med       Date:  1999-08       Impact factor: 0.142

Review 8.  Surgical management of pelvic organ prolapse in women.

Authors:  Christopher Maher; Benjamin Feiner; Kaven Baessler; Corina Schmid
Journal:  Cochrane Database Syst Rev       Date:  2013-04-30

Review 9.  Complication and reoperation rates after apical vaginal prolapse surgical repair: a systematic review.

Authors:  Gouri B Diwadkar; Matthew D Barber; Benjamin Feiner; Christopher Maher; J Eric Jelovsek
Journal:  Obstet Gynecol       Date:  2009-02       Impact factor: 7.661

10.  Symptomatic pelvic organ prolapse: prevalence and risk factors in a population-based, racially diverse cohort.

Authors:  Guri Rortveit; Jeanette S Brown; David H Thom; Stephen K Van Den Eeden; Jennifer M Creasman; Leslee L Subak
Journal:  Obstet Gynecol       Date:  2007-06       Impact factor: 7.661

  10 in total
  5 in total

Review 1.  Robotic Sacrocolpopexy-Is It the Treatment of Choice for Advanced Apical Pelvic Organ Prolapse?

Authors:  Janine L Oliver; Ja-Hong Kim
Journal:  Curr Urol Rep       Date:  2017-09       Impact factor: 3.092

2.  Entry into the peritoneal cavity in posthysterectomy prolapse: an educational video.

Authors:  C Emi Bretschneider; Karl Jallad; Patrick M Lang; Mickey M Karram; Mark D Walters
Journal:  Int Urogynecol J       Date:  2017-02-06       Impact factor: 2.894

3.  Procedure Choice in Primary Versus Recurrent Prolapse: A Study of Fellowship-Trained Surgeons.

Authors:  Rachel High; Alex Kavanagh; Rose Khavari; Julie Stewart; Danielle D Antosh
Journal:  Female Pelvic Med Reconstr Surg       Date:  2018 Jul/Aug       Impact factor: 2.091

4.  Symptom Relief and Retreatment After Vaginal, Open, or Robotic Surgery for Apical Vaginal Prolapse.

Authors:  Mallika Anand; Amy L Weaver; Kristin M Fruth; Emanuel C Trabuco; John B Gebhart
Journal:  Female Pelvic Med Reconstr Surg       Date:  2017 Sep/Oct       Impact factor: 2.091

5.  Perioperative Complications and Cost of Vaginal, Open Abdominal, and Robotic Surgery for Apical Vaginal Vault Prolapse.

Authors:  Mallika Anand; Amy L Weaver; Kristin M Fruth; Bijan J Borah; Christopher J Klingele; John B Gebhart
Journal:  Female Pelvic Med Reconstr Surg       Date:  2017 Jan/Feb       Impact factor: 2.091

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.